Km. Elased et al., Reversal of type 2 diabetes in mice by products of malaria parasites: I. Effect of inactivated parasites, METABOLISM, 49(7), 2000, pp. 937-941
C57BL/KsJ-db/db and C57BL/KsJ-ob/ob mice are good models for studies on hum
an obesity and type 2 diabetes. We have previously shown that infection wit
h blood-stage malaria or injection of extracts from malaria-parasitized red
blood cells induces hypoglycemia in normal mice and normalizes hyperglycem
ia in mice made moderately diabetic by streptozotocin. In the present study
, we show that a single intravenous (IV) injection of Formalin-fixed Plasmo
dium yoelii YM (FFYM) preparation decreases blood glucose in db/db mice fro
m an initial value of 19 mmol/L to a normal value of 7 mmol/L (P < .0001) f
or at least 24 hours and reduces food intake, Plasma insulin concentrations
in db/db mice were not altered. FFYM was also active in normal and ob/ob m
ice, an effect associated with an increase in plasma insulin. Although the
rate of weight gain in lean ob/+ and lean db/+ was not altered by this trea
tment, there was a significant reduction in weight gain in db/db and ob/ob
mice (P <.001). We suggest that malaria-derived molecules, when fully chara
cterized, may provide structural information for the development of new age
nts for the management of type 2 diabetes. Copyright (C) 2000 by W.B. Saund
ers Company.